DESIGN AND SYNTHESIS OF QUINOLINE ANALOGUES FOR HIV-1 INTEGRASE INHIBITION TO OVERCOME RESISTANCE AND TOXICITY

The ongoing battle against the human immunodeficiency virus (HIV) has led to significant advancements in antiretroviral therapies, particularly in the development of drugs targeting HIV-1 integrase (IN), an essential enzyme responsible for integrating viral DNA into the host genome. HIV-1 integrase inhibitors (INIs) have shown substantial promise as a therapeutic option, but the emergence of drug resistance and toxicity concerns have significantly hampered their long-term efficacy. This has prompted researchers to explore alternative strategies for designing and synthesizing novel quinoline analogues as potent HIV-1 integrase inhibitors, aimed at overcoming resistance mechanisms and minimizing toxicity.

• Sharma, Bechan. (2011). Anti-HIV-1 drug toxicity and management strategies. Neurobehavioral HIV Medicine, 3: 27-40. 10.2147/NBHIV.S11748.
• Marchand, Christophe & Maddali, Kasthuraiah & Métifiot, Mathieu & Pommier, Yves. (2009). HIV-1 IN inhibitors: 2010 update and perspectives. Current topics in medicinal chemistry, 9: 1016-37. 10.2174/156802609789630910.
• Mermer, Arif. (2021). Designing Potential HIV-1 Integrase Inhibitors: an In Silico Approach. Turkish Journal of Analytical Chemistry, 3. 10.51435/turkjac.950248.
• Anstett, Kaitlin & Brenner, Bluma & Mesplède, Thibault & Wainberg, Mark. (2017). HIV drug resistance against strand transfer integrase inhibitors. Retrovirology, 14. 10.1186/s12977-017-0360-7.
• Blanco, Jose & Whitlock, Gary & Milinkovic, Ana & Moyle, Graeme. (2015). HIV integrase inhibitors: A new era in the treatment of HIV. Expert opinion on pharmacotherapy, 16: 1313-1324. 10.1517/14656566.2015.1044436.
• Pryde, David & Webster, Rob & Butler, Scott & Murray, Edward & Whitby, Kevin & Pickford, Chris & Westby, Mike & Palmer, Michael & Bull, David & Vuong, Hannah & Blakemore, David & Stead, Darren & Ashcroft, Christopher & Gardner, Iain & Bru, Claire & Cheung, Wai-Yee & Roberts, Ieuan & Morton, Jennifer & Bissell, Richard. (2013). Discovery of an HIV integrase inhibitor with an excellent resistance profile. Med. Chem. Commun, 4: 709-719. 10.1039/C3MD00014A.
• Métifiot, Mathieu & Johnson, Barry & Smith, Steven & Zhao, XueZhi & Marchand, Christophe & Burke, Terrence & Hughes, Stephen & Pommier, Yves. (2011). MK-0536 Inhibits HIV-1 Integrases Resistant to Raltegravir. Antimicrobial agents and chemotherapy, 55: 5127-33. 10.1128/AAC.05288-11.
• Peese, Kevin & Naidu, B. & Patel, Manoj & Li, Chen & Langley, David & Protack, Tricia & Gali, Volodymyr & Lin, Zeyu & Samanta, Himadri & Zheng, Ming & Jenkins, Susan & Dicker, Ira & Krystal, Mark & Meanwell, Nicholas & Walker, Michael. (2019). Heterocycle amide isosteres: an approach to overcoming resistance for HIV-1 Integrase strand transfer inhibitors. Bioorganic & Medicinal Chemistry Letters, 30: 126784. 10.1016/j.bmcl.2019.126784.
• Peese, Kevin & Naidu, B. & Patel, Manoj & Li, Chen & Langley, David & Protack, Tricia & Gali, Volodymyr & Lin, Zeyu & Samanta, Himadri & Zheng, Ming & Jenkins, Susan & Dicker, Ira & Krystal, Mark & Meanwell, Nicholas & Walker, Michael. (2019). Heterocycle amide isosteres: an approach to overcoming resistance for HIV-1 Integrase strand transfer inhibitors. Bioorganic & Medicinal Chemistry Letters, 30: 126784. 10.1016/j.bmcl.2019.126784.
• Gordon, C & Griffith, R & Keller, Paul. (2007). Control of HIV Through the Inhibition of HIV-1 Integrase: A Medicinal Chemistry Perspective. Medicinal chemistry (Shāriqah (United Arab Emirates)), 3: 199-220. 10.2174/157340607780059558.
• Métifiot, Mathieu & Marchand, Christophe & Maddali, Kasthuraiah & Pommier, Yves. (2010). Resistance to Integrase Inhibitors. Viruses, 2:    1347-66. 10.3390/v2071347.
• Scarsi, Kimberly & Havens, Joshua & Podany, Anthony & Avedissian, Sean & Fletcher, Courtney. (2020). HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety. Drugs, 80. 10.1007/s40265-020-01379-9.
• Liao, Chenzhong & Marchand, Christophe & Burke, Terrence & Pommier, Yves & Nicklaus, Marc. (2010). Authentic HIV-1 Integrase Inhibitors. Future medicinal chemistry, 2: 1107-22. 10.4155/fmc.10.199.
• Mouscadet, Jean-Francois & delelis, Olivier & Marcelin, Anne-Geneviève & Tchertanov, Luba. (2010). Resistance to HIV-1 integrase inhibitors: A structural perspective. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy, 13: 139-50. 10.1016/j.drup.2010.05.001.
• Ingale, Kundan & Bhatia, Manish. (2011). HIV-1 Integrase Inhibitors: A Review of Their Chemical Development. Antiviral chemistry & chemotherapy, 22: 95-105. 10.3851/IMP1740.
• Chen, Shuguang & Chen, Ran & He, Meizi & Pang, Ruifang & Tan, Zhiwu & Yang, Ming. (2009). Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors. Bioorganic & medicinal chemistry, 17: 1948-56. 10.1016/j.bmc.2009.01.038.
• Musiol, Robert. (2012). Quinoline-based HIV Integrase Inhibitors. Current pharmaceutical design, 19. 10.2174/1381612811319100008.